Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg

Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg

The aim of the analysis was to describe the results of administration of pan-genotype antiviral therapy (glecaprevir / pibrentasvir, GLE / PIB) in real-world setting in three clinical centers in St. Petersburg within the city program for the treatment of chronic hepatitis C.   Materials and methods....

Full description

Saved in:
Bibliographic Details
Main Authors: D. A. Gusev, K. V. Zhdanov, K. V. Kozlov, T. N. Vinogradova, M. Yu. Kopot, V. S. Sukachev, S. S. Zhabrov, S. N. Kizhlo, S. Yu. Romanova, V. B. Musatov, N. V. Tyurenkova, Yu. A. Vlasova, E. Yu. Kolpashchikova, P. N. Fedorov, P. V. Minin, T. S. Korneeva
Format: Article
Language:Russian
Published: Journal Infectology 2023-01-01
Series:Журнал инфектологии
Subjects:
chronic hepatitis c
glecaprevir / pibrentasvir
pan-genotypic
real world evidence
Online Access:https://journal.niidi.ru/jofin/article/view/1427
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journal.niidi.ru/jofin/article/view/1427

Similar Items